# Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3

> **NCT01096082** · PHASE2,PHASE3 · COMPLETED · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 62 (actual)

## Conditions studied

- Spinocerebellar Ataxia Type 3
- Machado Joseph Disease

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01096082
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2013-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01096082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01096082, "Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01096082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*